1. Home
  2. AIFU vs SLGL Comparison

AIFU vs SLGL Comparison

Compare AIFU & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIFU
  • SLGL
  • Stock Information
  • Founded
  • AIFU 1998
  • SLGL 1997
  • Country
  • AIFU China
  • SLGL Israel
  • Employees
  • AIFU N/A
  • SLGL N/A
  • Industry
  • AIFU
  • SLGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • AIFU
  • SLGL Health Care
  • Exchange
  • AIFU NYSE
  • SLGL Nasdaq
  • Market Cap
  • AIFU 20.3M
  • SLGL 19.3M
  • IPO Year
  • AIFU 2007
  • SLGL 2018
  • Fundamental
  • Price
  • AIFU $8.17
  • SLGL $11.00
  • Analyst Decision
  • AIFU
  • SLGL Buy
  • Analyst Count
  • AIFU 0
  • SLGL 1
  • Target Price
  • AIFU N/A
  • SLGL $40.00
  • AVG Volume (30 Days)
  • AIFU 86.8K
  • SLGL 9.6K
  • Earning Date
  • AIFU 09-17-2025
  • SLGL 08-15-2025
  • Dividend Yield
  • AIFU N/A
  • SLGL N/A
  • EPS Growth
  • AIFU 61.54
  • SLGL N/A
  • EPS
  • AIFU 23.02
  • SLGL N/A
  • Revenue
  • AIFU $247,815,758.00
  • SLGL $12,103,000.00
  • Revenue This Year
  • AIFU N/A
  • SLGL N/A
  • Revenue Next Year
  • AIFU N/A
  • SLGL $31.17
  • P/E Ratio
  • AIFU $0.40
  • SLGL N/A
  • Revenue Growth
  • AIFU N/A
  • SLGL 603.66
  • 52 Week Low
  • AIFU $1.50
  • SLGL $3.34
  • 52 Week High
  • AIFU $9.40
  • SLGL $16.50
  • Technical
  • Relative Strength Index (RSI)
  • AIFU N/A
  • SLGL 80.53
  • Support Level
  • AIFU N/A
  • SLGL $9.17
  • Resistance Level
  • AIFU N/A
  • SLGL $8.49
  • Average True Range (ATR)
  • AIFU 0.00
  • SLGL 0.68
  • MACD
  • AIFU 0.00
  • SLGL 0.33
  • Stochastic Oscillator
  • AIFU 0.00
  • SLGL 97.35

About AIFU FANHUA INC SPON ADS EACH REPR 20 ORD SHS

AIFU Inc is an independent financial services provider in China. It offer end-to-end business solutions spanning compliance, technology, products, services, capital flow and professional training. It connects customers with insurance protection, retirement planning, health management, asset management, and family governance services. The company operated in two segments: the insurance agency segment, which derives maximum revenue, consists of providing agency services for distributing life insurance products and non-life insurance products on behalf of insurance companies, and the claims adjusting segment consisting of providing pre-underwriting survey services, claims adjusting services, disposal of residual value services, loading/unloading supervision services and consulting services.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: